Premium
P3‐412: INSULIN PROTECTS AGAINST BETA AMYLOID INDUCED HIPPOCAMPAL CELL DEATH
Author(s) -
Moosavi Maryam,
Moosavi Maryam,
Ghasemi Rasoul,
Zarifkar Asadollah,
Rastegar Karim,
Maghsoudi Nader
Publication year - 2014
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2014.05.1507
Subject(s) - insulin , protein kinase b , amyloid beta , viability assay , senile plaques , programmed cell death , hippocampal formation , western blot , medicine , endocrinology , insulin receptor , chemistry , biology , apoptosis , alzheimer's disease , disease , microbiology and biotechnology , phosphorylation , insulin resistance , biochemistry , gene
Background:The 5-HT6 receptor is primarily localized in the brain, in areas relevant for cognition. Combining a 5-HT6 receptor antagonist and an acetylcholinesterase inhibitor (AChEI) represents a promising new approach to the symptomatic treatment of Alzheimer’s disease. In a recent phase II trial, the selective 5-HT6 receptor antagonist Lu AE58054 improved cognition in patients with moderate Alzheimer’s disease on stable donepezil (AchEI) treatment. In rats, the increased power of oscillatory activity in deep brain regions has been linked to increased cognitive performance. In the present study, we investigated the ability of Lu AE58054 alone and in combinationwith donepezil tomodulate neuronal rhythms in themedial prefrontal cortex (mPFC).Methods: Cortical activity was recorded using intracranial mPFC electrodes in urethane anesthetized male Sprague Dawley rats. Electrical stimulation was applied to the brainstem reticular formation (0.3 ms square pulses delivered over 6 s at 250 Hz, repeated every 100 s). The power of oscillatory activity was compared between treatments to quantify the strength of the oscillation. Results: Intravenous (i.v.) injection of 2 mg/kg Lu AE58054 alone produced a transient increase in electricallyinduced gamma power. Furthermore, Lu AE58054 (2 mg/kg, i.v.) significantly potentiated the effect of donepezil (0.3 mg/kg i.v.) on brain-stem stimulation induced gamma oscillations. At 1 mg/kg i.v., Lu AE58054 alone did not increase gamma power in the mPFC, but did significantly potentiate the effect of donepezil (0.3 mg/kg i.v.). Conclusions: Lu AE58054 (2 mg/ kg, i.v.) increases gamma oscillations in the mPFC by electrical stimulation, such network activity believed to play a role in higher cognitive function. In addition, we demonstrated an add-on effect of Lu AE58054 (1 and 2 mg/kg i.v.) to donepezil (0.3 mg/kg i.v.). Such potentiation may contribute to the procognitive effects of Lu AE58054 in Alzheimer’s disease.